These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105. Fatal rhabdomyolysis in a patient with liver cirrhosis after switching from simvastatin to fluvastatin. Baek SD, Jang SJ, Park SE, Ok TJ, Leem J, Lee HS, Park SJ, Kim TH. J Korean Med Sci; 2011 Dec; 26(12):1634-7. PubMed ID: 22148003 [Abstract] [Full Text] [Related]
106. Reducing the risk of cardiovascular disease in older adults. Miller CA. Geriatr Nurs; 1994 Dec; 15(6):331-2. PubMed ID: 7835766 [No Abstract] [Full Text] [Related]
107. Oral anticoagulant drug interactions with statins: case report of fluvastatin and review of the literature. Andrus MR. Pharmacotherapy; 2004 Feb; 24(2):285-90. PubMed ID: 14998226 [Abstract] [Full Text] [Related]
108. Clinical practice guidelines for managing dyslipidemias in kidney transplant patients: lessons to be learnt from the assessment of Lescol in renal transplantation (ALERT) trial. Holdaas H, Fellström B, Jardine AG, ALERT Study Group. Am J Transplant; 2005 Jun; 5(6):1574-5. PubMed ID: 15888072 [No Abstract] [Full Text] [Related]
109. A retrospective analysis of the effect of noncompliance on time to first major adverse cardiac event in LIPS. Lesaffre E, Kocmanová D, Lemos PA, Disco CM, Serruys PW. Clin Ther; 2003 Sep; 25(9):2431-47. PubMed ID: 14604742 [Abstract] [Full Text] [Related]
110. Long-term cardiac outcomes in renal transplant recipients receiving fluvastatin: the ALERT extension study. Holdaas H, Fellström B, Cole E, Nyberg G, Olsson AG, Pedersen TR, Madsen S, Grönhagen-Riska C, Neumayer HH, Maes B, Ambühl P, Hartmann A, Staffler B, Jardine AG, Assessment of LEscol in Renal Transplantation (ALERT) Study Investigators. Am J Transplant; 2005 Dec; 5(12):2929-36. PubMed ID: 16303007 [Abstract] [Full Text] [Related]
111. The effect of statin therapy on arterial stiffness by measuring pulse wave velocity: a systematic review. Rizos EC, Agouridis AP, Elisaf MS. Curr Vasc Pharmacol; 2010 Sep; 8(5):638-44. PubMed ID: 20507272 [Abstract] [Full Text] [Related]
113. Genetic analysis of fluvastatin response and dyslipidemia in renal transplant recipients. Singer JB, Holdaas H, Jardine AG, Fellstrøm B, Os I, Bermann G, Meyer JM, Assessment of Lescol in Renal Transplantation (ALERT) Study Investigators. J Lipid Res; 2007 Sep; 48(9):2072-8. PubMed ID: 17563401 [Abstract] [Full Text] [Related]
114. Relation of statin use with non-melanoma skin cancer: prospective results from the Women's Health Initiative. Wang A, Stefanick ML, Kapphahn K, Hedlin H, Desai M, Manson JA, Strickler H, Martin L, Wactawski-Wende J, Simon M, Tang JY. Br J Cancer; 2016 Feb 02; 114(3):314-20. PubMed ID: 26742009 [Abstract] [Full Text] [Related]
115. Security and maximal tolerated doses of fluvastatin in pediatric cancer patients. López-Aguilar E, Sepúlveda-Vildósola AC, Rivera-Márquez H, Cerecedo-Diaz F, Valdez-Sánchez M, Villasis-Keever MA. Arch Med Res; 1999 Feb 02; 30(2):128-31. PubMed ID: 10372447 [Abstract] [Full Text] [Related]
117. Disposition of [3H]fluvastatin following single oral doses in beagle dogs and rhesus monkeys with bile fistulae. Tse FL, Dain JG, Kalafsky G. Biopharm Drug Dispos; 1995 Apr 02; 16(3):211-9. PubMed ID: 7787133 [Abstract] [Full Text] [Related]